Cor Jesus Fernandes Fontes

Cor Jesus Fernandes Fontes

Auto-generated profile, based on publicly available information

Cor Jesus Fernandes Fontes

Universidade Federal de Mato Grosso, Brazil

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2010 in Malaria Journal
Verified
Journal Article
Open access
PDF file
FCFernanda Mf Campos
Fernanda Mf Campos
BFBernardo S Franklin
Bernardo S Franklin
ATAndréa Teixeira-Carvalho
Andréa Teixeira-Carvalho
ASAgnaldo Silva-Filho
Agnaldo Silva-Filho
SPSálua Co de Paula
Sálua Co de Paula
LCLuzia H Carvalho
Luzia H Carvalho
Background: In the last few years, the study of microparticles (MPs) - submicron vesicles released from cells upon activation or apoptosis - has gained growing interest in the field of inflammation and in infectious diseases. Their role in the human malaria parasite Plasmodium vivax remains unexplored. Because acute vivax malaria has been related to pro-inflammatory responses, the main hypothesis investigated in this study was that Plasmodium vivax infection is associated with elevated levels of circulating MPs, which may play a role during acute disease in non-immune patients. Methods: Plasma MPs were analysed among thirty-seven uncomplicated P. vivax infections from an area of unstable malaria transmission in the Brazilian Amazon. The MP phenotype was analysed by flow cytometry using the classical MP marker, annexin, and fluorochrome-labeled monoclonal antibodies against specific cell surface markers. The frequencies of plasma MPs in P. vivax patients (n = 37) were further compared to malaria-unexposed controls (n = 15) and ovarian carcinoma patients (n = 12), a known MPs-inducing disease non-related to malaria. Results: The frequencies of plasma circulating MPs were markedly increased in P. vivax patients, as compared to healthy age-matched malaria-unexposed controls. Although platelets, erythrocytes and leukocytes were the main cellular sources of MPs during vivax malaria, platelet derived-MPs (PMPs) increased in a linear fashion with the presence of fever at the time of blood collection (β = 0.06, p < 0.0001) and length of acute symptoms (β = 0.36, p < 0.0001). Finally, the results suggest that plasma levels of PMPs diminish as patient experience more episodes of clinical malaria (β = 0.07, p < 0.003). Conclusions: Abundant circulating MPs are present during acute P. vivax infection, and platelet derived-MPs may play a role on the acute inflammatory symptoms of malaria vivax.

1 March 2010 in Mycoses
Verified
Journal Article
Closed access
PDF file
João Batista JúniorJoão Batista Júnior
João Batista Júnior
ZRZoilo Rodrigues
Zoilo Rodrigues
GFGeisa Ferreira Fernandes
Geisa Ferreira Fernandes
AVAdriana Pardini Vicentini
Adriana Pardini Vicentini
CFCor Jesus Fernandes Fontes
Cor Jesus Fernandes Fontes
RHRosane Hahn
Rosane Hahn

13 December 2011 in Malaria Journal
Verified
Journal Article
Open access
PDF file
EPElza A Pereira
Elza A Pereira
EIEdna Ay Ishikawa
Edna Ay Ishikawa
CFCor Jf Fontes
Cor Jf Fontes
Patients' adherence to malaria treatment is an important factor in determining the therapeutic response to anti-malarial drugs. It contributes to the patient's complete recovery and prevents the emergence of parasite resistance to anti-malarial drugs. In Brazil, the low compliance with malaria treatment probably explains the large number of Plasmodium vivax malaria relapses observed in the past years. The goal of this study was to estimate the proportion of patients adhering to the P. vivax malaria treatment with chloroquine + primaquine in the dosages recommended by the Brazilian Ministry of Health.

28 July 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ASAna Carolina Rios Silvino
Ana Carolina Rios Silvino
GCGabriel Luiz Costa
Gabriel Luiz Costa
FAFlávia Carolina Faustino De Araújo
Flávia Carolina Faustino De Araújo
DADavid Ascher
David Ascher
DPDouglas Pires
Douglas Pires
TSTais Nobrega Sousa
Tais Nobrega Sousa
Although Plasmodium vivax relapses are classically associated with hypnozoite activation, it has been proposed that a proportion of these cases are due to primaquine (PQ) treatment failure caused by polymorphisms in cytochrome P-450 2D6 (CYP2D6). Here, we present evidence that CYP2D6 polymorphisms are implicated in PQ failure, which was reinforced by findings in genetically similar parasites, and may explain a number of vivax relapses. Using a computational approach, these polymorphisms were predicted to affect the activity of CYP2D6 through changes in the structural stability that could lead to disruption of the PQ-enzyme interactions. Furthermore, because PQ is co-administered with chloroquine (CQ), we investigated whether CQ-impaired metabolism by cytochrome P-450 2C8 (CYP2C8) could also contribute to vivax recurrences. Our results show that CYP2C8-mutated patients frequently relapsed early (<42 days) and had a higher proportion of genetically similar parasites, suggesting the possibility of recrudescence due to CQ therapeutic failure. These results highlight the importance of pharmacogenetic studies as a tool to monitor the efficacy of antimalarial therapy.

1 May 2002 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
EBErika Martins Braga
Erika Martins Braga
RBRosa Maria Barros
Rosa Maria Barros
TRTã¢Nia Afonso Reis
Tã¢Nia Afonso Reis
CFCor Jesus F Fontes
Cor Jesus F Fontes
CMCristiane Guimarã£Es Morais
Cristiane Guimarã£Es Morais
AKAntoniana Ursine Krettli
Antoniana Ursine Krettli
The antibody response to the C-terminal 19-kD fragment of Plasmodium falciparum merozoite surface protein-1 (PfMSP1-19) was investigated in groups of subjects living in areas of Brazil with different levels of malaria transmission. The prevalence and the levels of IgG to PfMSP1-19 increased with the time of exposure and were positively correlated with the absence of clinical symptoms in parasitemic patients. The frequency of positive response and the mean level of IgG were higher in areas where malaria prevalence was more intense, especially among asymptomatic patients. The serum absorbance values of the IgG1 isotype were significantly higher among subjects with long-term exposure and in asymptomatic infections. These data suggest a protective role of IgG1 in naturally acquired immunity in spite of the unstable transmission levels in the Brazilian Amazon.

1 November 2001 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
EDE C Duarte
E C Duarte
LPL W Pang
L W Pang
LRL C Ribeiro
L C Ribeiro
CFC J Fontes
C J Fontes
This study evaluated the cure rate of the standard recommended regimen for Plasmodium vivax malaria in Brazil and assessed risk factors for failures. Fifty patients with vivax malaria given supervised medical treatment (standard dose of chloroquine: total dose = 1.5 g over a three-day period plus primaquine: total dose = 210 mg over a 14-day period) were followed for six months in a non-endemic area. Cox's regression was used to identify predictors of relapses. Among the 289 patient-months of follow-up, seven relapses were identified (2.4 relapses per 100 person-months) between 33 and 137 days after treatment initiation. Risk factors for relapses (P < or = 0.05) were female sex, higher parasitemia at baseline, shorter number of days with symptoms prior to baseline, and lower mg/kg dose of primaquine. Relapses following supervised vivax treatment is in principle a necessary, but not sufficient, component of in vivo parasite resistance. Results indicate that other factors, principally sub-therapeutic primaquine doses, may explain the occurrence of vivax treatment failures.